Advertisement

Investigation of oxidative stress markers and antioxidant enzymes activity in newly diagnosed type 2 diabetes patients and healthy subjects, association with IL-6 level

  • Zahra Arab Sadeghabadi
  • Roghayeh Abbasalipourkabir
  • Roohollah Mohseni
  • Nasrin ZiamajidiEmail author
Research article
  • 11 Downloads

Abstract

Objective

Oxidative stress and inflammation play an important role in the pathogenesis of diabetes and its complication. In this study, we aimed to evaluate and compare oxidative stress markers and antioxidant enzymes activity, as well as Interleukin 6 (IL-6) level in newly diagnosed type 2 diabetes mellitus (T2DM) patients and healthy subjects.

Material and methods

30 newly diagnosed type 2 diabetes patients and 30 healthy subjects (age and sex matched) were recruited in this study. After anthropometric parameters measurement, blood sample were collected from all participant. Serum and plasma were isolated. Biochemical parameters were evaluated in serum. Plasma was used to measure malondialdehyde (MDA), total oxidant status (TOS), total antioxidant capacity (TAC) levels, as well as superoxide dismutase (SOD) and glutathione peroxidase (GPx) activity. Also, IL-6 level was investigated in plasma using ELISA method.

Results

MDA and TOS levels were significantly higher in T2DM patients than the control group (p < 0.05). However, TAC and SOD were significantly lower in T2DM as compared with healthy subjects (p < 0.05). Also, IL-6 level was higher in T2DM in comparison to healthy subjects (p = 0.004). Furthermore, there was a significant positive correlation between IL-6 with MDA (p = 0.031, r = 0.482) and TOS (p < 0.001, r = 0.744). In addition, a negative correlation was observed between IL-6 and SOD activity (p = 0.002, r = −0.660).

Conclusion

Reducing oxidative stress and inflammation could be effective in improvement of T2DM.

Keywords

Type 2 diabetes mellitus (T2DM) Malondialdehyde (MDA) Total oxidant status (TOS) Total antioxidant capacity (TAC) Superoxide dismutase (SOD) and glutathione peroxidase (GPx) Interleukin 6 (IL-6) 

Notes

Acknowledgments

We would like to thank staff of Hamadan Health Center for providing assistance.

Funding information

This study was financially supported by Hamadan University of Medical Sciences (Grant Number: 9612087760).

Compliance with ethical standards

Conflict of interest

The authors declare no conflict of interest.

References

  1. 1.
    Ngaski A. Correlation of antioxidants enzymes activity with fasting blood glucose in diabetic patients in Sokoto, Nigeria. British J Med Med Res. 2018;25(12):1–6.CrossRefGoogle Scholar
  2. 2.
    Holy B, Ngoye BO. Clinical relevance of superoxide dismutase and glutathione peroxidase levels in management of diabetes Type2. Int J Contemp Med Res. 2016;3(5):1380–2.Google Scholar
  3. 3.
    Aouacheri O, Saka S, Krim M, Messaadia A, Maidi I. The investigation of the oxidative stress-related parameters in type 2 diabetes mellitus. Can J Diabetes. 2015;39(1):44–9.CrossRefGoogle Scholar
  4. 4.
    Kaefer M, Piva SJ, De Carvalho JA, Da Silva DB, Becker AM, Coelho AC, et al. Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus. Clin Biochem. 2010;43(4–5):450–4.CrossRefGoogle Scholar
  5. 5.
    Hisalkar P, Patne A, Fawade M, Karnik A. Evaluation of plasma superoxide dismutase and glutathione peroxidase in type 2 diabetic patients. Biol Med. 2012;4(2):65.Google Scholar
  6. 6.
    Rochette L, Zeller M, Cottin Y, Vergely C. Diabetes, oxidative stress and therapeutic strategies. Biochimica et Biophysica Acta (BBA)-General Subjects. 2014;1840(9):2709–29.CrossRefGoogle Scholar
  7. 7.
    Briggs ON, Brown H, Elechi-amadi K, Ezeiruaku F, Nduka N. Superoxide Dismutase and Glutathione Peroxidase Levels in Patients with Long Standing Type 2 Diabetes in Port Harcourt, Rivers State, Nigeria. 2016;5(3):1282–1288.Google Scholar
  8. 8.
    Chattopadhyay M, Khemka VK, Chatterjee G, Ganguly A, Mukhopadhyay S, Chakrabarti S. Enhanced ROS production and oxidative damage in subcutaneous white adipose tissue mitochondria in obese and type 2 diabetes subjects. Mol Cell Biochem. 2015;399(1–2):95–103.CrossRefGoogle Scholar
  9. 9.
    Mohseni R, Sadeghabadi ZA, Goodarzi MT, Teimouri M, Nourbakhsh M, Azar MR. Evaluation of Mn-superoxide dismutase and catalase gene expression in childhood obesity: its association with insulin resistance. J Pediatr Endocrinol Metab. 2018;31(7):727–32.CrossRefGoogle Scholar
  10. 10.
    Sadeghabadi ZA, Ziamajidi N, Abbasalipourkabir R, Mohseni R, Borzouei S. Palmitate-induced IL6 expression ameliorated by chicoric acid through AMPK and SIRT1-mediated pathway in the PBMCs of newly diagnosed type 2 diabetes patients and healthy subjects. Cytokine. 2019;116:106–14.CrossRefGoogle Scholar
  11. 11.
    Mohseni R, Sadeghabadi ZA, Ziamajidi N, Abbasalipourkabir R, Rezaei Farimani A. Oral administration of resveratrol-loaded solid lipid nanoparticle improves insulin resistance through targeting expression of SNARE proteins in adipose and muscle tissue in rats with type 2 diabetes. Nanoscale Res Lett. 2019;14(1):227.CrossRefGoogle Scholar
  12. 12.
    Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38(12):1103–11.CrossRefGoogle Scholar
  13. 13.
    Benzie IF, Strain J. [2] Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol 299: Elsevier; 1999. 15–27.Google Scholar
  14. 14.
    Shah N, Shah R. Alteration in enzymatic antioxidant defense in diabetes mellitus. Biomed Res. 2012;23:3.Google Scholar
  15. 15.
    Acharya AB, Thakur S, Muddapur MV, Kulkarni RD. Tumor necrosis factor-α, interleukin-4 and-6 in the serum of health, chronic periodontitis, and type 2 diabetes mellitus. J Indian Soc Periodontol. 2016;20(5):509.CrossRefGoogle Scholar
  16. 16.
    Bandeira SM, Guedes GS, Fonseca LJS, Pires AS, Gelain DP, Moreira JCF, et al. Characterization of blood oxidative stress in type 2 diabetes mellitus patients: increase in lipid peroxidation and SOD activity. Oxidative Med Cell Longev. 2012;2012.Google Scholar
  17. 17.
    Sadi G, Güray T. Gene expressions of Mn-SOD and GPx-1 in streptozotocin-induced diabetes: effect of antioxidants. Mol Cell Biochem. 2009;327(1–2):127–34.CrossRefGoogle Scholar
  18. 18.
    Elmarakby AA, Sullivan JC. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy. Cardiovasc Ther. 2012;30(1):49–59.CrossRefGoogle Scholar
  19. 19.
    Ertürk C, Altay MA, Bilge A, Çelik H. Is there a relationship between serum ox-LDL, oxidative stress, and PON1 in knee osteoarthritis? Clin Rheumatol. 2017;36(12):2775–80.CrossRefGoogle Scholar
  20. 20.
    Li J-J, Oberley LW, Fan M, Colburn NH. Inhibition of AP-1 and NF-κB by manganese-containing superoxide dismutase in human breast cancer cells. FASEB J. 1998;12(15):1713–23.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Clinical Biochemistry, School of MedicineHamadan University of Medical SciencesHamadanIran
  2. 2.Molecular Medicine Research CenterHamadan University of Medical SciencesHamadanIran

Personalised recommendations